STOCK TITAN
  1. Home
  2. PFNX

PFENEX (PFNX) Stock Price, News & Analysis

PFNX NYSE

Company Description

PFENEX (NYSE: PFNX) is classified in the biotechnology industry within the Health Technology sector.

This page collects what Stock Titan holds for PFNX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

management
+1.47%

Pfenex to Announce Second Quarter Financial Results on August 6

earnings
-7.12%

Pfenex Announces Positive European CHMP Opinion for PF708 (EU Brand Name: Livogiva™) and New Partnership in Latin America, and Provides CRM197 Business Update

partnership
+5.60%

Pfenex Announces U.S. Commercial Launch of Teriparatide Injection

+3.31%

Pfenex to Participate in the William Blair Growth Stock Conference

conferences
+2.88%

Pfenex Reports First Quarter 2020 Results and Provides Business Update

earnings

PFENEX has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include management, earnings, partnership, conferences. View all PFNX news →

SEC Filings

View All

No SEC filings available for PFNX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PFNX Company Profile & Sector Positioning

PFENEX (PFNX) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NYSE.